Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Co-phenotrope 2.5mg/0.025mg tablets
0104020H0AAAAAA
|
Co-phenotrope | Co-phenotrope (Diphenox hydrochloride/atropine sulfate) | Gastro-Intestinal System | 584 |
|
Lomotil 2.5mg/25microgram tablets (Imported)
0104020H0BBAEAA
|
Lomotil | Co-phenotrope (Diphenox hydrochloride/atropine sulfate) | Gastro-Intestinal System | 20 |
|
Lofenoxal 2.5mg/25microgram tablets
0104020H0BGAAAA
|
Lofenoxal | Co-phenotrope (Diphenox hydrochloride/atropine sulfate) | Gastro-Intestinal System | 3 |
|
Dymotil 2.5mg/25microgram tablets
0104020H0BFAAAA
|
Dymotil | Co-phenotrope (Diphenox hydrochloride/atropine sulfate) | Gastro-Intestinal System | No data available |
|
Lomotil 2.5mg/25microgram tablets (Advanz Phamra)
0104020H0BBAAAA
|
Lomotil | Co-phenotrope (Diphenox hydrochloride/atropine sulfate) | Gastro-Intestinal System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.